IL-12 DNA Displays efficient adjuvant effects improving immunogenicity of Ag85A in DNA prime/MVA boost immunizations
Mycobacterium tuberculosis (Mtb) infection is one of the leading causes of death worldwide. The Modified Vaccinia Ankara (MVA) vaccine vector expressing the mycobacterial antigen 85A (MVA85A) was demonstrated to be safe, although it did not improve BCG efficacy, denoting the need to search for improved tuberculosis vaccines. In this work, we investigated the effect of IL-12 DNA -as an adjuvant- on an Ag85A DNA prime/MVA85A boost vaccination regimen. We evaluated the immune response profile elicited in mice and the protection conferred against intratracheal Mtb H37Rv challenge. We observed that the immunization scheme including DNA-A85A+DNA-IL-12/MVA85A induced a strong IFN-γ production to Ag85A in vitro, with a significant expansion of IFN-γ+CD4+ and IFN-γ+CD8+ anti-Ag85A lymphocytes. Furthermore, we also detected a significant increase in the proportion of specific CD8+CD107+ T cells against Ag85A. Additionally, inclusion of IL-12 DNA in the DNA-A85A/MVA85A vaccine scheme induced a marked augment in anti-Ag85A IgG levels. Interestingly, after 30 days of infection with Mtb H37Rv, DNA-A85A+DNA-IL-12/MVA85A vaccinated mice displayed a significant reduction in lung bacterial burden. Together, our findings suggest that IL-12 DNA might be useful as a molecular adjuvant in an Ag85A DNA/MVA prime-boost vaccine against Mtb infection.
Principais autores: | Morelli, María Paula, Del Medico Zajac, Maria Paula, Pellegrini, Joaquín Miguel, Amiano, Nicolás Oscar, Tateosian, Nancy Liliana, Calamante, Gabriela, Gherardi, Maria Magdalena, García, Verónica Edith |
---|---|
Formato: | info:ar-repo/semantics/artículo biblioteca |
Idioma: | eng |
Publicado em: |
Frontiers Media
2020-09
|
Assuntos: | Vaccine Adjuvants, Immunogenetics, Coadyuvantes de Vacunas, Tuberculosis, Mycobacterium Tuberculosis, Inmunogenética, Ag85A, IL-12, MVA, |
Acesso em linha: | http://hdl.handle.net/20.500.12123/8630 https://www.frontiersin.org/articles/10.3389/fcimb.2020.581812/full https://doi.org/10.3389/fcimb.2020.581812 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma
por: Di Sciullo, Maria Paula, et al.
Publicado em: (2019-06) -
A plasmid encoding the extracellular domain of CD40 ligand and MontanideTM GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1
por: Kornuta, Claudia Alejandra, et al.
Publicado em: (2021-02) -
Replication and transmission features of two experimental vaccine candidates against bovine tuberculosis subcutaneously administrated in a murine model
por: Ferrara Muñiz, Ximena, et al.
Publicado em: (2022-05) -
MANα1-2MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV-1
por: Kornuta, Claudia Alejandra, et al.
Publicado em: (2021-03) -
Deletion of A44L, A46R and C12L vaccinia virus genes from the MVA genome improved the vector immunogenicity by modifying the innate immune response generating enhanced and optimized specific T-Cell responses
por: Holgado, María Pía, et al.
Publicado em: (2016-05)